These compounds may interact with:
Serine/threonine-protein kinase PLK1
Potentially involved in: kidney cancer; carcinoma; cancer; transient tic disorder; neutropenia; glioma; leukemia; atypical teratoid / rhabdoid tumor; breast cancer; breast carcinoma; glioblastoma; invasive ductal carcinoma; lung adenocarcinoma; malignant mesothelioma; medulloblastoma; medulloblastoma, large-cell; non-small cell lung cancer; osteosarcoma; psoriasis
Disease data sourced from Pharos.